Botulinum toxin type A in experimental neuropathic pain
- PMID: 15657640
- DOI: 10.1007/s00702-004-0265-1
Botulinum toxin type A in experimental neuropathic pain
Abstract
A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic nerve transection as a classical model of surgical neuropathy.
Similar articles
-
Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats.Eur J Pain. 2006 Oct;10(7):573-9. doi: 10.1016/j.ejpain.2005.08.006. Epub 2005 Oct 7. Eur J Pain. 2006. PMID: 16214382
-
Peripheral neuropathy induces cutaneous hypersensitivity in chronically spinalized rats.Pain Med. 2013 Jul;14(7):1057-71. doi: 10.1111/pme.12123. Epub 2013 Apr 22. Pain Med. 2013. PMID: 23855791
-
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.Eur J Pharmacol. 2010 May 10;633(1-3):10-4. doi: 10.1016/j.ejphar.2010.01.020. Epub 2010 Feb 1. Eur J Pharmacol. 2010. PMID: 20123097
-
Updates on the antinociceptive mechanism hypothesis of botulinum toxin A.Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S28-33. doi: 10.1016/j.parkreldis.2011.06.013. Parkinsonism Relat Disord. 2011. PMID: 21999893 Review.
-
A focused review on the use of botulinum toxins for neuropathic pain.Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S177-81. doi: 10.1097/00002508-200211001-00010. Clin J Pain. 2002. PMID: 12569966 Review.
Cited by
-
Therapeutic use of botulinum toxin in pain treatment.Neuronal Signal. 2018 Aug 31;2(3):NS20180058. doi: 10.1042/NS20180058. eCollection 2018 Sep. Neuronal Signal. 2018. PMID: 32714587 Free PMC article. Review.
-
Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.J Neural Transm (Vienna). 2016 Dec;123(12):1415-1421. doi: 10.1007/s00702-016-1611-9. Epub 2016 Sep 1. J Neural Transm (Vienna). 2016. PMID: 27586162 Review.
-
Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.J Neural Transm (Vienna). 2009 Oct;116(10):1273-80. doi: 10.1007/s00702-009-0285-y. Epub 2009 Aug 20. J Neural Transm (Vienna). 2009. PMID: 19693434
-
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury.Microorganisms. 2022 Apr 24;10(5):886. doi: 10.3390/microorganisms10050886. Microorganisms. 2022. PMID: 35630331 Free PMC article. Review.
-
Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain.Front Mol Neurosci. 2021 Oct 29;14:772719. doi: 10.3389/fnmol.2021.772719. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34776867 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical